COMPOSITE FORMULATION FOR ORAL ADMINISTRATION COMPRISING EZETIMIBE AND ROSUVASTATIN

摘要

Provided are a forming composite formulation for oral administration and a preparing method thereof. A forming composite formulation includes an ezetimibe granula part including ezetimibe having average particle size (d(0.9)) of lowest 90% of granula of 10 μm or less; and a rosuvastatin mix part including rosuvastating and a pharmaceutically acceptable salt thereof.